Hassard James
Insider CIK 1799357 · CRNX Chief Commercial Officer · ARWR Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-07-05 | 2024-07-09 | 15,000 | — | $0 | 130,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-07-05 | 2024-07-09 | 15,000 | $44.08 | $661.2K | 29,259 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-07-05 | 2024-07-09 | 15,000 | $19.73 | $295.9K | 44,259 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-06-21 | 2024-06-24 | 15,000 | — | $0 | 145,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-06-21 | 2024-06-24 | 15,000 | $19.73 | $295.9K | 44,259 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-06-21 | 2024-06-24 | 15,000 | $44.66 | $669.9K | 29,259 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | F Tax w/h | 2024-03-18 | 2024-03-20 | 1,741 | $38.14 | $66.4K | 29,259 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2024-03-04 | 2024-03-06 | 63,000 | — | $0 | 63,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2024-03-04 | 2024-03-06 | 17,000 | — | $0 | 31,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2023-03-01 | 2023-03-03 | 65,250 | — | $0 | 65,250 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2023-03-01 | 2023-03-03 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-03-10 | 2022-03-10 | 160,000 | — | $0 | 160,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-06-22 | 2021-06-24 | 3,625 | $89.22 | $323.4K | 105,750 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-01-07 | 2021-01-08 | 15,625 | $75.00 | $1.17M | 109,375 | SEC↗ |